Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Contribution of influenza viruses to medically attended acute respiratory illnesses in children in high-income countries: a meta-analysis.

Buchan SA, Hottes TS, Rosella LC, Crowcroft NS, Tran D, Kwong JC.

Influenza Other Respir Viruses. 2016 Nov;10(6):444-454. doi: 10.1111/irv.12400. Epub 2016 Aug 18.

2.

The Saudi Thoracic Society guidelines for influenza vaccinations.

Zeitouni MO, Al Barrak AM, Al-Moamary MS, Alharbi NS, Idrees MM, Al Shimemeri AA, Al-Hajjaj MS.

Ann Thorac Med. 2015 Oct-Dec;10(4):223-30. doi: 10.4103/1817-1737.167065.

3.

Strategies for Early Vaccination During Novel Influenza Outbreaks.

Laskowski M, Xiao Y, Charland N, Moghadas SM.

Sci Rep. 2015 Dec 14;5:18062. doi: 10.1038/srep18062.

4.

Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013.

Turner N, Pierse N, Bissielo A, Huang Q, Radke S, Baker M, Widdowson M, Kelly H; SHIVERS investigation team.

Euro Surveill. 2014 Aug 28;19(34). pii: 20884. Erratum in: Euro Surveill. 2015;20(25). pii: 21165. Euro Surveill. 2014;19(35). pii:20887.

5.

The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012.

Turner N, Pierse N, Bissielo A, Huang QS, Baker MG, Widdowson MA, Kelly H; SHIVERS investigation team.

Vaccine. 2014 Jun 17;32(29):3687-93. doi: 10.1016/j.vaccine.2014.04.013. Epub 2014 Apr 24.

6.

Pediatric sepsis: important considerations for diagnosing and managing severe infections in infants, children, and adolescents.

Randolph AG, McCulloh RJ.

Virulence. 2014 Jan 1;5(1):179-89. doi: 10.4161/viru.27045. Epub 2013 Nov 13. Review.

7.

Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children.

Salleras L, Navas E, Torner N, Prat AA, Garrido P, Soldevila N, Domínguez A.

Hum Vaccin Immunother. 2013 Mar;9(3):707-11. Epub 2013 Jan 7.

8.

Vaccine herd effect.

Kim TH, Johnstone J, Loeb M.

Scand J Infect Dis. 2011 Sep;43(9):683-9. doi: 10.3109/00365548.2011.582247. Epub 2011 May 23. Review.

9.

Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants.

D'Angio CT, Heyne RJ, Duara S, Holmes LC, O'Shea TM, Wang H, Wang D, Sánchez PJ, Welliver RC, Ryan RM, Schnabel KC, Hall CB; Premature Infant Vaccine Collaborative.

Pediatr Infect Dis J. 2011 Jul;30(7):570-4. doi: 10.1097/INF.0b013e31820c1fdf.

10.

Projection of seasonal influenza severity from sequence and serological data.

Wolf YI, Nikolskaya A, Cherry JL, Viboud C, Koonin E, Lipman DJ.

PLoS Curr. 2010 Dec 3;2:RRN1200. doi: 10.1371/currents.RRN1200.

11.

Marketing paediatric influenza vaccination: results of a major metropolitan trial.

Van Buynder PG, Carcione D, Rettura V, Daly A, Woods E.

Influenza Other Respir Viruses. 2011 Jan;5(1):33-8. doi: 10.1111/j.1750-2659.2010.00167.x. Epub 2010 Aug 24.

12.

CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults.

Seidel A, Smith D, Yung E, Aquino L, Srivastava T, Pullarkat V, Spielberger R, Forman SJ, Diamond DJ.

Biol Blood Marrow Transplant. 2011 Apr;17(4):524-33. doi: 10.1016/j.bbmt.2010.04.015. Epub 2010 May 8.

13.

Age groups and spread of influenza: implications for vaccination strategy.

Hsieh YH.

BMC Infect Dis. 2010 Apr 30;10:106. doi: 10.1186/1471-2334-10-106.

14.

A stiff-legged gait: benign acute childhood myositis.

Jain S, Kolber MR.

CMAJ. 2009 Nov 10;181(10):711-3. doi: 10.1503/cmaj.090781. Epub 2009 Oct 13. No abstract available.

15.

Influenza.

Jefferson T.

BMJ Clin Evid. 2009 Mar 12;2009. pii: 0911. Review.

16.

Antibody responses after inactivated influenza vaccine in young children.

Wright PF, Sannella E, Shi JR, Zhu Y, Ikizler MR, Edwards KM.

Pediatr Infect Dis J. 2008 Nov;27(11):1004-8. doi: 10.1097/INF.0b013e31817d53c5.

17.

Mitigation measures for pandemic influenza in Italy: an individual based model considering different scenarios.

Ciofi degli Atti ML, Merler S, Rizzo C, Ajelli M, Massari M, Manfredi P, Furlanello C, Scalia Tomba G, Iannelli M.

PLoS One. 2008 Mar 12;3(3):e1790. doi: 10.1371/journal.pone.0001790.

18.

Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review.

Jefferson T, Foxlee R, Del Mar C, Dooley L, Ferroni E, Hewak B, Prabhala A, Nair S, Rivetti A.

BMJ. 2008 Jan 12;336(7635):77-80. Epub 2007 Nov 27. Review.

19.

Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects.

Block SL, Reisinger KS, Hultquist M, Walker RE; CAIV-T Study Group.

Antimicrob Agents Chemother. 2007 Nov;51(11):4001-8. Epub 2007 Aug 27.

20.

Seasonal influenza in the United States, France, and Australia: transmission and prospects for control.

Chowell G, Miller MA, Viboud C.

Epidemiol Infect. 2008 Jun;136(6):852-64. Epub 2007 Jul 18.

Supplemental Content

Support Center